company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,FY,,2009-12-31,2011-02-17 07:30:53+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,207075000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,FY,,2009-12-31,2011-02-17 07:30:53+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,134255000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,FY,,2009-12-31,2011-02-17 07:30:53+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,65568000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,FY,,2009-12-31,2011-02-17 07:30:53+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,18610000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,FY,,2009-12-31,2011-02-17 07:30:53+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,425508000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,FY,,2009-12-31,2011-02-17 07:30:53+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,259676000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,FY,,2009-12-31,2011-02-17 07:30:53+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,48680000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,FY,,2009-12-31,2011-02-17 07:30:53+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,7338000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,FY,,2009-12-31,2011-02-17 07:30:53+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,56018000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,FY,,2009-12-31,2011-02-17 07:30:53+00:00,,totalassets,Total Assets,=,debit,usd,741202000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,FY,,2009-12-31,2011-02-17 07:30:53+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,FY,,2009-12-31,2011-02-17 07:30:53+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,49031000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,FY,,2009-12-31,2011-02-17 07:30:53+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,44544000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,FY,,2009-12-31,2011-02-17 07:30:53+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,93575000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,FY,,2009-12-31,2011-02-17 07:30:53+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,109022000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,FY,,2009-12-31,2011-02-17 07:30:53+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,137884000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,FY,,2009-12-31,2011-02-17 07:30:53+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,3959000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,FY,,2009-12-31,2011-02-17 07:30:53+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,250865000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,FY,,2009-12-31,2011-02-17 07:30:53+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,344440000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,FY,,2009-12-31,2011-02-17 07:30:53+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,FY,,2009-12-31,2011-02-17 07:30:53+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,2000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,FY,,2009-12-31,2011-02-17 07:30:53+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,1336811000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,FY,,2009-12-31,2011-02-17 07:30:53+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-941095000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,FY,,2009-12-31,2011-02-17 07:30:53+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,1044000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,FY,,2009-12-31,2011-02-17 07:30:53+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,396760000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,FY,,2009-12-31,2011-02-17 07:30:53+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,396762000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,FY,,2009-12-31,2011-02-17 07:30:53+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,396762000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,FY,,2009-12-31,2011-02-17 07:30:53+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,741202000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,FY,,2010-12-31,2012-02-21 07:31:08+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,112572000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,FY,,2010-12-31,2012-02-21 07:31:08+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,136796000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,FY,,2010-12-31,2012-02-21 07:31:08+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,81917000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,FY,,2010-12-31,2012-02-21 07:31:08+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,26337000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,FY,,2010-12-31,2012-02-21 07:31:08+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,357622000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,FY,,2010-12-31,2012-02-21 07:31:08+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,347450000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,FY,,2010-12-31,2012-02-21 07:31:08+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,377571000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,FY,,2010-12-31,2012-02-21 07:31:08+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,6789000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,FY,,2010-12-31,2012-02-21 07:31:08+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,384360000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,FY,,2010-12-31,2012-02-21 07:31:08+00:00,,totalassets,Total Assets,=,debit,usd,1089432000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,FY,,2010-12-31,2012-02-21 07:31:08+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,675000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,FY,,2010-12-31,2012-02-21 07:31:08+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,53658000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,FY,,2010-12-31,2012-02-21 07:31:08+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,54723000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,FY,,2010-12-31,2012-02-21 07:31:08+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,109056000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,FY,,2010-12-31,2012-02-21 07:31:08+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,FY,,2010-12-31,2012-02-21 07:31:08+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,159355000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,FY,,2010-12-31,2012-02-21 07:31:08+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,285856000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,FY,,2010-12-31,2012-02-21 07:31:08+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,7350000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,FY,,2010-12-31,2012-02-21 07:31:08+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,452561000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,FY,,2010-12-31,2012-02-21 07:31:08+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,561617000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,FY,,2010-12-31,2012-02-21 07:31:08+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,FY,,2010-12-31,2012-02-21 07:31:08+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,FY,,2010-12-31,2012-02-21 07:31:08+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,1575867000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,FY,,2010-12-31,2012-02-21 07:31:08+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-1045563000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,FY,,2010-12-31,2012-02-21 07:31:08+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-2491000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,FY,,2010-12-31,2012-02-21 07:31:08+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,527813000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,FY,,2010-12-31,2012-02-21 07:31:08+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,527815000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,FY,,2010-12-31,2012-02-21 07:31:08+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,527815000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,FY,,2010-12-31,2012-02-21 07:31:08+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,1089432000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3,,2010-09-30,2010-10-28 07:33:17+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,325286000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3,,2010-09-30,2010-10-28 07:33:17+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,153767000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3,,2010-09-30,2010-10-28 07:33:17+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,82287000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3,,2010-09-30,2010-10-28 07:33:17+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,14379000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3,,2010-09-30,2010-10-28 07:33:17+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,575719000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3,,2010-09-30,2010-10-28 07:33:17+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,318498000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3,,2010-09-30,2010-10-28 07:33:17+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,37956000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3,,2010-09-30,2010-10-28 07:33:17+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,6860000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3,,2010-09-30,2010-10-28 07:33:17+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,3400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3,,2010-09-30,2010-10-28 07:33:17+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,48216000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3,,2010-09-30,2010-10-28 07:33:17+00:00,,totalassets,Total Assets,=,debit,usd,942433000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3,,2010-09-30,2010-10-28 07:33:17+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,634000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3,,2010-09-30,2010-10-28 07:33:17+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,74976000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3,,2010-09-30,2010-10-28 07:33:17+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,58223000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3,,2010-09-30,2010-10-28 07:33:17+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,133833000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3,,2010-09-30,2010-10-28 07:33:17+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,158382000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3,,2010-09-30,2010-10-28 07:33:17+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,296865000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3,,2010-09-30,2010-10-28 07:33:17+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,5289000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3,,2010-09-30,2010-10-28 07:33:17+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,460536000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3,,2010-09-30,2010-10-28 07:33:17+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,594369000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3,,2010-09-30,2010-10-28 07:33:17+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3,,2010-09-30,2010-10-28 07:33:17+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3,,2010-09-30,2010-10-28 07:33:17+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,1379203000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3,,2010-09-30,2010-10-28 07:33:17+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-1030966000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3,,2010-09-30,2010-10-28 07:33:17+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-175000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3,,2010-09-30,2010-10-28 07:33:17+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,348062000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3,,2010-09-30,2010-10-28 07:33:17+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,348064000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3,,2010-09-30,2010-10-28 07:33:17+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,348064000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3,,2010-09-30,2010-10-28 07:33:17+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,942433000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2,,2010-06-30,2010-07-28 07:30:36+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,112000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2,,2010-06-30,2010-07-28 07:30:36+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,194337000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2,,2010-06-30,2010-07-28 07:30:36+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,95196000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2,,2010-06-30,2010-07-28 07:30:36+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,16217000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2,,2010-06-30,2010-07-28 07:30:36+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,417750000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2,,2010-06-30,2010-07-28 07:30:36+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,292329000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2,,2010-06-30,2010-07-28 07:30:36+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,70465000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2,,2010-06-30,2010-07-28 07:30:36+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,6697000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2,,2010-06-30,2010-07-28 07:30:36+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,3400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2,,2010-06-30,2010-07-28 07:30:36+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,80562000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2,,2010-06-30,2010-07-28 07:30:36+00:00,,totalassets,Total Assets,=,debit,usd,790641000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2,,2010-06-30,2010-07-28 07:30:36+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,448000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2,,2010-06-30,2010-07-28 07:30:36+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,58256000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2,,2010-06-30,2010-07-28 07:30:36+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,60867000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2,,2010-06-30,2010-07-28 07:30:36+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,119571000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2,,2010-06-30,2010-07-28 07:30:36+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,157359000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2,,2010-06-30,2010-07-28 07:30:36+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,138177000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2,,2010-06-30,2010-07-28 07:30:36+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,4318000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2,,2010-06-30,2010-07-28 07:30:36+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,299854000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2,,2010-06-30,2010-07-28 07:30:36+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,419425000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2,,2010-06-30,2010-07-28 07:30:36+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2,,2010-06-30,2010-07-28 07:30:36+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2,,2010-06-30,2010-07-28 07:30:36+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,1368611000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2,,2010-06-30,2010-07-28 07:30:36+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-997091000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2,,2010-06-30,2010-07-28 07:30:36+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-306000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2,,2010-06-30,2010-07-28 07:30:36+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,371214000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2,,2010-06-30,2010-07-28 07:30:36+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,371216000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2,,2010-06-30,2010-07-28 07:30:36+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,371216000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2,,2010-06-30,2010-07-28 07:30:36+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,790641000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,FY,,2011-12-31,2013-02-15 16:13:21+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,483610000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,FY,,2011-12-31,2013-02-15 16:13:21+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,43332000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,FY,,2011-12-31,2013-02-15 16:13:21+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,103035000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,FY,,2011-12-31,2013-02-15 16:13:21+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,35800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,FY,,2011-12-31,2013-02-15 16:13:21+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,FY,,2011-12-31,2013-02-15 16:13:21+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,665777000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,FY,,2011-12-31,2013-02-15 16:13:21+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,367955000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,FY,,2011-12-31,2013-02-15 16:13:21+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,283608000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,FY,,2011-12-31,2013-02-15 16:13:21+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,FY,,2011-12-31,2013-02-15 16:13:21+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,6243000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,FY,,2011-12-31,2013-02-15 16:13:21+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,289851000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,FY,,2011-12-31,2013-02-15 16:13:21+00:00,,totalassets,Total Assets,=,debit,usd,1323583000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,FY,,2011-12-31,2013-02-15 16:13:21+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,1006000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,FY,,2011-12-31,2013-02-15 16:13:21+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,95625000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,FY,,2011-12-31,2013-02-15 16:13:21+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,51640000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,FY,,2011-12-31,2013-02-15 16:13:21+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,148271000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,FY,,2011-12-31,2013-02-15 16:13:21+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,275019000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,FY,,2011-12-31,2013-02-15 16:13:21+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,159508000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,FY,,2011-12-31,2013-02-15 16:13:21+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,248610000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,FY,,2011-12-31,2013-02-15 16:13:21+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,6443000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,FY,,2011-12-31,2013-02-15 16:13:21+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,689580000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,FY,,2011-12-31,2013-02-15 16:13:21+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,837851000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,FY,,2011-12-31,2013-02-15 16:13:21+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,FY,,2011-12-31,2013-02-15 16:13:21+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,FY,,2011-12-31,2013-02-15 16:13:21+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,1754824000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,FY,,2011-12-31,2013-02-15 16:13:21+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-1267323000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,FY,,2011-12-31,2013-02-15 16:13:21+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-1862000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,FY,,2011-12-31,2013-02-15 16:13:21+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,485639000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,FY,,2011-12-31,2013-02-15 16:13:21+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,485732000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,FY,,2011-12-31,2013-02-15 16:13:21+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,485732000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,FY,,2011-12-31,2013-02-15 16:13:21+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,1323583000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3,,2011-09-30,2011-10-27 07:31:02+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,206395000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3,,2011-09-30,2011-10-27 07:31:02+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,39103000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3,,2011-09-30,2011-10-27 07:31:02+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,78447000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3,,2011-09-30,2011-10-27 07:31:02+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,15927000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3,,2011-09-30,2011-10-27 07:31:02+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,339872000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3,,2011-09-30,2011-10-27 07:31:02+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,363913000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3,,2011-09-30,2011-10-27 07:31:02+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,266223000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3,,2011-09-30,2011-10-27 07:31:02+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,13023000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3,,2011-09-30,2011-10-27 07:31:02+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,279246000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3,,2011-09-30,2011-10-27 07:31:02+00:00,,totalassets,Total Assets,=,debit,usd,983031000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3,,2011-09-30,2011-10-27 07:31:02+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,920000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3,,2011-09-30,2011-10-27 07:31:02+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,78890000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3,,2011-09-30,2011-10-27 07:31:02+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,53425000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3,,2011-09-30,2011-10-27 07:31:02+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,133235000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3,,2011-09-30,2011-10-27 07:31:02+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,159482000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3,,2011-09-30,2011-10-27 07:31:02+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,254656000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3,,2011-09-30,2011-10-27 07:31:02+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,7405000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3,,2011-09-30,2011-10-27 07:31:02+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,421543000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3,,2011-09-30,2011-10-27 07:31:02+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,554778000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3,,2011-09-30,2011-10-27 07:31:02+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3,,2011-09-30,2011-10-27 07:31:02+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3,,2011-09-30,2011-10-27 07:31:02+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,1643864000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3,,2011-09-30,2011-10-27 07:31:02+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-1213880000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3,,2011-09-30,2011-10-27 07:31:02+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-1731000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3,,2011-09-30,2011-10-27 07:31:02+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,428253000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3,,2011-09-30,2011-10-27 07:31:02+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,428253000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3,,2011-09-30,2011-10-27 07:31:02+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,428253000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3,,2011-09-30,2011-10-27 07:31:02+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,983031000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2,,2011-06-30,2011-07-28 07:30:53+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,254312000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2,,2011-06-30,2011-07-28 07:30:53+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,55371000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2,,2011-06-30,2011-07-28 07:30:53+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,84564000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2,,2011-06-30,2011-07-28 07:30:53+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,19026000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2,,2011-06-30,2011-07-28 07:30:53+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,413273000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2,,2011-06-30,2011-07-28 07:30:53+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,361883000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2,,2011-06-30,2011-07-28 07:30:53+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,259421000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2,,2011-06-30,2011-07-28 07:30:53+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,12287000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2,,2011-06-30,2011-07-28 07:30:53+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,271708000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2,,2011-06-30,2011-07-28 07:30:53+00:00,,totalassets,Total Assets,=,debit,usd,1046864000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2,,2011-06-30,2011-07-28 07:30:53+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,877000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2,,2011-06-30,2011-07-28 07:30:53+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,81665000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2,,2011-06-30,2011-07-28 07:30:53+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,53326000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2,,2011-06-30,2011-07-28 07:30:53+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,135868000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2,,2011-06-30,2011-07-28 07:30:53+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,159457000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2,,2011-06-30,2011-07-28 07:30:53+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,266699000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2,,2011-06-30,2011-07-28 07:30:53+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,6806000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2,,2011-06-30,2011-07-28 07:30:53+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,432962000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2,,2011-06-30,2011-07-28 07:30:53+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,568830000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2,,2011-06-30,2011-07-28 07:30:53+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2,,2011-06-30,2011-07-28 07:30:53+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2,,2011-06-30,2011-07-28 07:30:53+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,1630453000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2,,2011-06-30,2011-07-28 07:30:53+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-1151515000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2,,2011-06-30,2011-07-28 07:30:53+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-904000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2,,2011-06-30,2011-07-28 07:30:53+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,478034000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2,,2011-06-30,2011-07-28 07:30:53+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,478034000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2,,2011-06-30,2011-07-28 07:30:53+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,478034000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2,,2011-06-30,2011-07-28 07:30:53+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,1046864000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1,,2011-03-31,2011-05-03 07:30:45+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,135376000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1,,2011-03-31,2011-05-03 07:30:45+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,91065000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1,,2011-03-31,2011-05-03 07:30:45+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,88156000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1,,2011-03-31,2011-05-03 07:30:45+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,10904000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1,,2011-03-31,2011-05-03 07:30:45+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,325501000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1,,2011-03-31,2011-05-03 07:30:45+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,357423000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1,,2011-03-31,2011-05-03 07:30:45+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,381141000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1,,2011-03-31,2011-05-03 07:30:45+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,10228000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1,,2011-03-31,2011-05-03 07:30:45+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,391369000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1,,2011-03-31,2011-05-03 07:30:45+00:00,,totalassets,Total Assets,=,debit,usd,1074293000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1,,2011-03-31,2011-05-03 07:30:45+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,798000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1,,2011-03-31,2011-05-03 07:30:45+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,58602000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1,,2011-03-31,2011-05-03 07:30:45+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,52852000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1,,2011-03-31,2011-05-03 07:30:45+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,112252000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1,,2011-03-31,2011-05-03 07:30:45+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,159353000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1,,2011-03-31,2011-05-03 07:30:45+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,277417000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1,,2011-03-31,2011-05-03 07:30:45+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,7180000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1,,2011-03-31,2011-05-03 07:30:45+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,443950000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1,,2011-03-31,2011-05-03 07:30:45+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,556202000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1,,2011-03-31,2011-05-03 07:30:45+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1,,2011-03-31,2011-05-03 07:30:45+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1,,2011-03-31,2011-05-03 07:30:45+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,1609274000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1,,2011-03-31,2011-05-03 07:30:45+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-1089010000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1,,2011-03-31,2011-05-03 07:30:45+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-2175000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1,,2011-03-31,2011-05-03 07:30:45+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,518089000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1,,2011-03-31,2011-05-03 07:30:45+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,518091000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1,,2011-03-31,2011-05-03 07:30:45+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,518091000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1,,2011-03-31,2011-05-03 07:30:45+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,1074293000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,FY,,2012-12-31,2014-02-13 16:07:14+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,230276000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,FY,,2012-12-31,2014-02-13 16:07:14+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,77819000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,FY,,2012-12-31,2014-02-13 16:07:14+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,693120000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,FY,,2012-12-31,2014-02-13 16:07:14+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,28638000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,FY,,2012-12-31,2014-02-13 16:07:14+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,28025000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,FY,,2012-12-31,2014-02-13 16:07:14+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,148134000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,FY,,2012-12-31,2014-02-13 16:07:14+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,1206012000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,FY,,2012-12-31,2014-02-13 16:07:14+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,379940000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,FY,,2012-12-31,2014-02-13 16:07:14+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,279416000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,FY,,2012-12-31,2014-02-13 16:07:14+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,192022000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,FY,,2012-12-31,2014-02-13 16:07:14+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,23100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,FY,,2012-12-31,2014-02-13 16:07:14+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,494538000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,FY,,2012-12-31,2014-02-13 16:07:14+00:00,,totalassets,Total Assets,=,debit,usd,2080490000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,FY,,2012-12-31,2014-02-13 16:07:14+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,1374000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,FY,,2012-12-31,2014-02-13 16:07:14+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,111345000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,FY,,2012-12-31,2014-02-13 16:07:14+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,50831000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,FY,,2012-12-31,2014-02-13 16:07:14+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,163550000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,FY,,2012-12-31,2014-02-13 16:07:14+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,296518000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,FY,,2012-12-31,2014-02-13 16:07:14+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,159436000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,FY,,2012-12-31,2014-02-13 16:07:14+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,208342000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,FY,,2012-12-31,2014-02-13 16:07:14+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,7259000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,FY,,2012-12-31,2014-02-13 16:07:14+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,671555000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,FY,,2012-12-31,2014-02-13 16:07:14+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,835105000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,FY,,2012-12-31,2014-02-13 16:07:14+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,FY,,2012-12-31,2014-02-13 16:07:14+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,FY,,2012-12-31,2014-02-13 16:07:14+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,1763508000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,FY,,2012-12-31,2014-02-13 16:07:14+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-517054000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,FY,,2012-12-31,2014-02-13 16:07:14+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-1166000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,FY,,2012-12-31,2014-02-13 16:07:14+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,1245288000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,FY,,2012-12-31,2014-02-13 16:07:14+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,1245385000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,FY,,2012-12-31,2014-02-13 16:07:14+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,1245385000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,FY,,2012-12-31,2014-02-13 16:07:14+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,2080490000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3,,2012-09-30,2012-10-24 07:29:40+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,118998000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3,,2012-09-30,2012-10-24 07:29:40+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,143554000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3,,2012-09-30,2012-10-24 07:29:40+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,601271000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3,,2012-09-30,2012-10-24 07:29:40+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,84780000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3,,2012-09-30,2012-10-24 07:29:40+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,948603000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3,,2012-09-30,2012-10-24 07:29:40+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,372917000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3,,2012-09-30,2012-10-24 07:29:40+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,320773000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3,,2012-09-30,2012-10-24 07:29:40+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,18322000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3,,2012-09-30,2012-10-24 07:29:40+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,339095000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3,,2012-09-30,2012-10-24 07:29:40+00:00,,totalassets,Total Assets,=,debit,usd,1660615000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3,,2012-09-30,2012-10-24 07:29:40+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,1277000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3,,2012-09-30,2012-10-24 07:29:40+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,124224000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3,,2012-09-30,2012-10-24 07:29:40+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,53067000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3,,2012-09-30,2012-10-24 07:29:40+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,178568000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3,,2012-09-30,2012-10-24 07:29:40+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,290959000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3,,2012-09-30,2012-10-24 07:29:40+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,159499000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3,,2012-09-30,2012-10-24 07:29:40+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,218578000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3,,2012-09-30,2012-10-24 07:29:40+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,6987000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3,,2012-09-30,2012-10-24 07:29:40+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,676023000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3,,2012-09-30,2012-10-24 07:29:40+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,854591000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3,,2012-09-30,2012-10-24 07:29:40+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3,,2012-09-30,2012-10-24 07:29:40+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3,,2012-09-30,2012-10-24 07:29:40+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,1795389000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3,,2012-09-30,2012-10-24 07:29:40+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-987461000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3,,2012-09-30,2012-10-24 07:29:40+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-1904000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3,,2012-09-30,2012-10-24 07:29:40+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,806024000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3,,2012-09-30,2012-10-24 07:29:40+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,806024000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3,,2012-09-30,2012-10-24 07:29:40+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,806024000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3,,2012-09-30,2012-10-24 07:29:40+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,1660615000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2,,2012-06-30,2012-07-25 07:00:24+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,171943000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2,,2012-06-30,2012-07-25 07:00:24+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,129079000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2,,2012-06-30,2012-07-25 07:00:24+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,435380000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2,,2012-06-30,2012-07-25 07:00:24+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,32791000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2,,2012-06-30,2012-07-25 07:00:24+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,769193000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2,,2012-06-30,2012-07-25 07:00:24+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,372278000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2,,2012-06-30,2012-07-25 07:00:24+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,296462000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2,,2012-06-30,2012-07-25 07:00:24+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,19567000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2,,2012-06-30,2012-07-25 07:00:24+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,316029000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2,,2012-06-30,2012-07-25 07:00:24+00:00,,totalassets,Total Assets,=,debit,usd,1457500000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2,,2012-06-30,2012-07-25 07:00:24+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,1183000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2,,2012-06-30,2012-07-25 07:00:24+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,126768000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2,,2012-06-30,2012-07-25 07:00:24+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,55269000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2,,2012-06-30,2012-07-25 07:00:24+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,183220000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2,,2012-06-30,2012-07-25 07:00:24+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,285491000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2,,2012-06-30,2012-07-25 07:00:24+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,159558000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2,,2012-06-30,2012-07-25 07:00:24+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,227312000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2,,2012-06-30,2012-07-25 07:00:24+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,7262000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2,,2012-06-30,2012-07-25 07:00:24+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,679623000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2,,2012-06-30,2012-07-25 07:00:24+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,862843000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2,,2012-06-30,2012-07-25 07:00:24+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2,,2012-06-30,2012-07-25 07:00:24+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2,,2012-06-30,2012-07-25 07:00:24+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,1775957000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2,,2012-06-30,2012-07-25 07:00:24+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-1178929000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2,,2012-06-30,2012-07-25 07:00:24+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-2371000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2,,2012-06-30,2012-07-25 07:00:24+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,594657000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2,,2012-06-30,2012-07-25 07:00:24+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,594657000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2,,2012-06-30,2012-07-25 07:00:24+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,594657000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2,,2012-06-30,2012-07-25 07:00:24+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,1457500000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1,,2012-03-31,2012-04-26 07:31:17+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,394585000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1,,2012-03-31,2012-04-26 07:31:17+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,37713000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1,,2012-03-31,2012-04-26 07:31:17+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,238347000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1,,2012-03-31,2012-04-26 07:31:17+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,26270000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1,,2012-03-31,2012-04-26 07:31:17+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,696915000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1,,2012-03-31,2012-04-26 07:31:17+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,369959000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1,,2012-03-31,2012-04-26 07:31:17+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,262892000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1,,2012-03-31,2012-04-26 07:31:17+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,20393000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1,,2012-03-31,2012-04-26 07:31:17+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,283285000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1,,2012-03-31,2012-04-26 07:31:17+00:00,,totalassets,Total Assets,=,debit,usd,1350159000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1,,2012-03-31,2012-04-26 07:31:17+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,1093000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1,,2012-03-31,2012-04-26 07:31:17+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,106723000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1,,2012-03-31,2012-04-26 07:31:17+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,52570000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1,,2012-03-31,2012-04-26 07:31:17+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,160386000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1,,2012-03-31,2012-04-26 07:31:17+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,280206000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1,,2012-03-31,2012-04-26 07:31:17+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,159534000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1,,2012-03-31,2012-04-26 07:31:17+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,238554000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1,,2012-03-31,2012-04-26 07:31:17+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,7455000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1,,2012-03-31,2012-04-26 07:31:17+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,685749000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1,,2012-03-31,2012-04-26 07:31:17+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,846135000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1,,2012-03-31,2012-04-26 07:31:17+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1,,2012-03-31,2012-04-26 07:31:17+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1,,2012-03-31,2012-04-26 07:31:17+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,1761033000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1,,2012-03-31,2012-04-26 07:31:17+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-1255672000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1,,2012-03-31,2012-04-26 07:31:17+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-1337000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1,,2012-03-31,2012-04-26 07:31:17+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,504024000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1,,2012-03-31,2012-04-26 07:31:17+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,504024000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1,,2012-03-31,2012-04-26 07:31:17+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,504024000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1,,2012-03-31,2012-04-26 07:31:17+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,1350159000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,FY,,2013-12-31,2015-02-12 16:39:16+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,535608000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,FY,,2013-12-31,2015-02-12 16:39:16+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,158376000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,FY,,2013-12-31,2015-02-12 16:39:16+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,954967000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,FY,,2013-12-31,2015-02-12 16:39:16+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,70354000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,FY,,2013-12-31,2015-02-12 16:39:16+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,32952000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,FY,,2013-12-31,2015-02-12 16:39:16+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,44677000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,FY,,2013-12-31,2015-02-12 16:39:16+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,1796934000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,FY,,2013-12-31,2015-02-12 16:39:16+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,526983000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,FY,,2013-12-31,2015-02-12 16:39:16+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,389891000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,FY,,2013-12-31,2015-02-12 16:39:16+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,231878000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,FY,,2013-12-31,2015-02-12 16:39:16+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,5327000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,FY,,2013-12-31,2015-02-12 16:39:16+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,627096000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,FY,,2013-12-31,2015-02-12 16:39:16+00:00,,totalassets,Total Assets,=,debit,usd,2951013000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,FY,,2013-12-31,2015-02-12 16:39:16+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,250896000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,FY,,2013-12-31,2015-02-12 16:39:16+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,47000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,FY,,2013-12-31,2015-02-12 16:39:16+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,939000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,FY,,2013-12-31,2015-02-12 16:39:16+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,298835000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,FY,,2013-12-31,2015-02-12 16:39:16+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,320315000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,FY,,2013-12-31,2015-02-12 16:39:16+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,184258000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,FY,,2013-12-31,2015-02-12 16:39:16+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,184199000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,FY,,2013-12-31,2015-02-12 16:39:16+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,11330000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,FY,,2013-12-31,2015-02-12 16:39:16+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,700102000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,FY,,2013-12-31,2015-02-12 16:39:16+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,998937000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,FY,,2013-12-31,2015-02-12 16:39:16+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,FY,,2013-12-31,2015-02-12 16:39:16+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,FY,,2013-12-31,2015-02-12 16:39:16+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,2045857000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,FY,,2013-12-31,2015-02-12 16:39:16+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-92692000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,FY,,2013-12-31,2015-02-12 16:39:16+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,FY,,2013-12-31,2015-02-12 16:39:16+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-1188000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,FY,,2013-12-31,2015-02-12 16:39:16+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,1951977000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,FY,,2013-12-31,2015-02-12 16:39:16+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,1952076000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,FY,,2013-12-31,2015-02-12 16:39:16+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,1952076000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,FY,,2013-12-31,2015-02-12 16:39:16+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,2951013000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3,,2013-09-30,2013-11-05 07:14:08+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,263211000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3,,2013-09-30,2013-11-05 07:14:08+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,182112000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3,,2013-09-30,2013-11-05 07:14:08+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,992824000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3,,2013-09-30,2013-11-05 07:14:08+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,156839000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3,,2013-09-30,2013-11-05 07:14:08+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,39174000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3,,2013-09-30,2013-11-05 07:14:08+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,1634160000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3,,2013-09-30,2013-11-05 07:14:08+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,453891000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3,,2013-09-30,2013-11-05 07:14:08+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,329863000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3,,2013-09-30,2013-11-05 07:14:08+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,218092000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3,,2013-09-30,2013-11-05 07:14:08+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,4409000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3,,2013-09-30,2013-11-05 07:14:08+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,552364000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3,,2013-09-30,2013-11-05 07:14:08+00:00,,totalassets,Total Assets,=,debit,usd,2640415000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3,,2013-09-30,2013-11-05 07:14:08+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,794000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3,,2013-09-30,2013-11-05 07:14:08+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,219138000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3,,2013-09-30,2013-11-05 07:14:08+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,48795000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3,,2013-09-30,2013-11-05 07:14:08+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,268727000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3,,2013-09-30,2013-11-05 07:14:08+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,314162000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3,,2013-09-30,2013-11-05 07:14:08+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,167219000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3,,2013-09-30,2013-11-05 07:14:08+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,189563000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3,,2013-09-30,2013-11-05 07:14:08+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,10573000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3,,2013-09-30,2013-11-05 07:14:08+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,681517000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3,,2013-09-30,2013-11-05 07:14:08+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,950244000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3,,2013-09-30,2013-11-05 07:14:08+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3,,2013-09-30,2013-11-05 07:14:08+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3,,2013-09-30,2013-11-05 07:14:08+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,1882520000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3,,2013-09-30,2013-11-05 07:14:08+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-189498000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3,,2013-09-30,2013-11-05 07:14:08+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-2851000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3,,2013-09-30,2013-11-05 07:14:08+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,1690171000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3,,2013-09-30,2013-11-05 07:14:08+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,1690171000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3,,2013-09-30,2013-11-05 07:14:08+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,1690171000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3,,2013-09-30,2013-11-05 07:14:08+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,2640415000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2,,2013-06-30,2013-08-06 07:10:00+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,381675000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2,,2013-06-30,2013-08-06 07:10:00+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,155831000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2,,2013-06-30,2013-08-06 07:10:00+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,876016000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2,,2013-06-30,2013-08-06 07:10:00+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,108913000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2,,2013-06-30,2013-08-06 07:10:00+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,38927000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2,,2013-06-30,2013-08-06 07:10:00+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,1561362000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2,,2013-06-30,2013-08-06 07:10:00+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,419651000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2,,2013-06-30,2013-08-06 07:10:00+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,173328000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2,,2013-06-30,2013-08-06 07:10:00+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,208707000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2,,2013-06-30,2013-08-06 07:10:00+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,15211000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2,,2013-06-30,2013-08-06 07:10:00+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,397246000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2,,2013-06-30,2013-08-06 07:10:00+00:00,,totalassets,Total Assets,=,debit,usd,2378259000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2,,2013-06-30,2013-08-06 07:10:00+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,794000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2,,2013-06-30,2013-08-06 07:10:00+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,153826000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2,,2013-06-30,2013-08-06 07:10:00+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,49182000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2,,2013-06-30,2013-08-06 07:10:00+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,203802000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2,,2013-06-30,2013-08-06 07:10:00+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,308116000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2,,2013-06-30,2013-08-06 07:10:00+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,164392000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2,,2013-06-30,2013-08-06 07:10:00+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,198412000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2,,2013-06-30,2013-08-06 07:10:00+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,10200000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2,,2013-06-30,2013-08-06 07:10:00+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,681120000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2,,2013-06-30,2013-08-06 07:10:00+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,884922000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2,,2013-06-30,2013-08-06 07:10:00+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2,,2013-06-30,2013-08-06 07:10:00+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2,,2013-06-30,2013-08-06 07:10:00+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,1827570000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2,,2013-06-30,2013-08-06 07:10:00+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-330804000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2,,2013-06-30,2013-08-06 07:10:00+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-3429000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2,,2013-06-30,2013-08-06 07:10:00+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,1493337000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2,,2013-06-30,2013-08-06 07:10:00+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,1493337000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2,,2013-06-30,2013-08-06 07:10:00+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,1493337000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2,,2013-06-30,2013-08-06 07:10:00+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,2378259000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1,,2013-03-31,2013-05-03 10:20:35+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,180362000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1,,2013-03-31,2013-05-03 10:20:35+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,127348000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1,,2013-03-31,2013-05-03 10:20:35+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,802638000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1,,2013-03-31,2013-05-03 10:20:35+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,97142000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1,,2013-03-31,2013-05-03 10:20:35+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,99632000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1,,2013-03-31,2013-05-03 10:20:35+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,1307122000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1,,2013-03-31,2013-05-03 10:20:35+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,392378000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1,,2013-03-31,2013-05-03 10:20:35+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,355101000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1,,2013-03-31,2013-05-03 10:20:35+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,201319000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1,,2013-03-31,2013-05-03 10:20:35+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,20078000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1,,2013-03-31,2013-05-03 10:20:35+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,576498000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1,,2013-03-31,2013-05-03 10:20:35+00:00,,totalassets,Total Assets,=,debit,usd,2275998000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1,,2013-03-31,2013-05-03 10:20:35+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,1473000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1,,2013-03-31,2013-05-03 10:20:35+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,145413000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1,,2013-03-31,2013-05-03 10:20:35+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,50358000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1,,2013-03-31,2013-05-03 10:20:35+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,197244000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1,,2013-03-31,2013-05-03 10:20:35+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,302268000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1,,2013-03-31,2013-05-03 10:20:35+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,159007000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1,,2013-03-31,2013-05-03 10:20:35+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,202345000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1,,2013-03-31,2013-05-03 10:20:35+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,8786000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1,,2013-03-31,2013-05-03 10:20:35+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,672406000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1,,2013-03-31,2013-05-03 10:20:35+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,869650000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1,,2013-03-31,2013-05-03 10:20:35+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1,,2013-03-31,2013-05-03 10:20:35+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1,,2013-03-31,2013-05-03 10:20:35+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,1826172000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1,,2013-03-31,2013-05-03 10:20:35+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-418180000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1,,2013-03-31,2013-05-03 10:20:35+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-1644000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1,,2013-03-31,2013-05-03 10:20:35+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,1406348000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1,,2013-03-31,2013-05-03 10:20:35+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,1406348000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1,,2013-03-31,2013-05-03 10:20:35+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,1406348000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1,,2013-03-31,2013-05-03 10:20:35+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,2275998000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,FY,,2014-12-31,2016-02-11 16:45:24+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,648719000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,FY,,2014-12-31,2016-02-11 16:45:24+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,251761000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,FY,,2014-12-31,2016-02-11 16:45:24+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,976372000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,FY,,2014-12-31,2016-02-11 16:45:24+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,128861000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,FY,,2014-12-31,2016-02-11 16:45:24+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,79046000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,FY,,2014-12-31,2016-02-11 16:45:24+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,2084759000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,FY,,2014-12-31,2016-02-11 16:45:24+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,974309000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,FY,,2014-12-31,2016-02-11 16:45:24+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,460154000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,FY,,2014-12-31,2016-02-11 16:45:24+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,315416000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,FY,,2014-12-31,2016-02-11 16:45:24+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,3034000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,FY,,2014-12-31,2016-02-11 16:45:24+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,778604000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,FY,,2014-12-31,2016-02-11 16:45:24+00:00,,totalassets,Total Assets,=,debit,usd,3837672000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,FY,,2014-12-31,2016-02-11 16:45:24+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,483489000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,FY,,2014-12-31,2016-02-11 16:45:24+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,74025000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,FY,,2014-12-31,2016-02-11 16:45:24+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,97146000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,FY,,2014-12-31,2016-02-11 16:45:24+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,654660000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,FY,,2014-12-31,2016-02-11 16:45:24+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,146773000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,FY,,2014-12-31,2016-02-11 16:45:24+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,310938000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,FY,,2014-12-31,2016-02-11 16:45:24+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,135249000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,FY,,2014-12-31,2016-02-11 16:45:24+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,39801000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,FY,,2014-12-31,2016-02-11 16:45:24+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,632761000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,FY,,2014-12-31,2016-02-11 16:45:24+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,1287421000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,FY,,2014-12-31,2016-02-11 16:45:24+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,FY,,2014-12-31,2016-02-11 16:45:24+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,FY,,2014-12-31,2016-02-11 16:45:24+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,2450782000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,FY,,2014-12-31,2016-02-11 16:45:24+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,216644000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,FY,,2014-12-31,2016-02-11 16:45:24+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-169530000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,FY,,2014-12-31,2016-02-11 16:45:24+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,52251000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,FY,,2014-12-31,2016-02-11 16:45:24+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,2550147000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,FY,,2014-12-31,2016-02-11 16:45:24+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,2550251000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,FY,,2014-12-31,2016-02-11 16:45:24+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,2550251000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,FY,,2014-12-31,2016-02-11 16:45:24+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,3837672000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3,,2014-09-30,2014-11-04 07:06:24+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,646554000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3,,2014-09-30,2014-11-04 07:06:24+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,395650000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3,,2014-09-30,2014-11-04 07:06:24+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,927254000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3,,2014-09-30,2014-11-04 07:06:24+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,120317000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3,,2014-09-30,2014-11-04 07:06:24+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,61732000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3,,2014-09-30,2014-11-04 07:06:24+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,49005000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3,,2014-09-30,2014-11-04 07:06:24+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,2200512000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3,,2014-09-30,2014-11-04 07:06:24+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,818967000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3,,2014-09-30,2014-11-04 07:06:24+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,453443000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3,,2014-09-30,2014-11-04 07:06:24+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,263081000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3,,2014-09-30,2014-11-04 07:06:24+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,3416000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3,,2014-09-30,2014-11-04 07:06:24+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,719940000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3,,2014-09-30,2014-11-04 07:06:24+00:00,,totalassets,Total Assets,=,debit,usd,3739419000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3,,2014-09-30,2014-11-04 07:06:24+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,1252000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3,,2014-09-30,2014-11-04 07:06:24+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,337976000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3,,2014-09-30,2014-11-04 07:06:24+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,70972000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3,,2014-09-30,2014-11-04 07:06:24+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,410200000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3,,2014-09-30,2014-11-04 07:06:24+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,287950000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3,,2014-09-30,2014-11-04 07:06:24+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,276112000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3,,2014-09-30,2014-11-04 07:06:24+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,189622000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3,,2014-09-30,2014-11-04 07:06:24+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,23747000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3,,2014-09-30,2014-11-04 07:06:24+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,777431000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3,,2014-09-30,2014-11-04 07:06:24+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,1187631000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3,,2014-09-30,2014-11-04 07:06:24+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3,,2014-09-30,2014-11-04 07:06:24+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,2423434000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3,,2014-09-30,2014-11-04 07:06:24+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,145206000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3,,2014-09-30,2014-11-04 07:06:24+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-43849000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3,,2014-09-30,2014-11-04 07:06:24+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,26895000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3,,2014-09-30,2014-11-04 07:06:24+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,2551686000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3,,2014-09-30,2014-11-04 07:06:24+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,2551788000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3,,2014-09-30,2014-11-04 07:06:24+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,2551788000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3,,2014-09-30,2014-11-04 07:06:24+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,3739419000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2,,2014-06-30,2014-08-05 06:52:44+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,600135000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2,,2014-06-30,2014-08-05 06:52:44+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,216774000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2,,2014-06-30,2014-08-05 06:52:44+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,893924000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2,,2014-06-30,2014-08-05 06:52:44+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,109897000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2,,2014-06-30,2014-08-05 06:52:44+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,60674000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2,,2014-06-30,2014-08-05 06:52:44+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,37291000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2,,2014-06-30,2014-08-05 06:52:44+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,1918695000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2,,2014-06-30,2014-08-05 06:52:44+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,707321000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2,,2014-06-30,2014-08-05 06:52:44+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,550818000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2,,2014-06-30,2014-08-05 06:52:44+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,270367000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2,,2014-06-30,2014-08-05 06:52:44+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,8877000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2,,2014-06-30,2014-08-05 06:52:44+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,830062000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2,,2014-06-30,2014-08-05 06:52:44+00:00,,totalassets,Total Assets,=,debit,usd,3456078000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2,,2014-06-30,2014-08-05 06:52:44+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,1060000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2,,2014-06-30,2014-08-05 06:52:44+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,283385000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2,,2014-06-30,2014-08-05 06:52:44+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,67133000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2,,2014-06-30,2014-08-05 06:52:44+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,351578000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2,,2014-06-30,2014-08-05 06:52:44+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,282261000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2,,2014-06-30,2014-08-05 06:52:44+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,234525000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2,,2014-06-30,2014-08-05 06:52:44+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,203904000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2,,2014-06-30,2014-08-05 06:52:44+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,14968000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2,,2014-06-30,2014-08-05 06:52:44+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,735658000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2,,2014-06-30,2014-08-05 06:52:44+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,1087236000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2,,2014-06-30,2014-08-05 06:52:44+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2,,2014-06-30,2014-08-05 06:52:44+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,2342941000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2,,2014-06-30,2014-08-05 06:52:44+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,65486000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2,,2014-06-30,2014-08-05 06:52:44+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-43848000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2,,2014-06-30,2014-08-05 06:52:44+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,4263000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2,,2014-06-30,2014-08-05 06:52:44+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,2368842000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2,,2014-06-30,2014-08-05 06:52:44+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,2368842000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2,,2014-06-30,2014-08-05 06:52:44+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,2368842000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2,,2014-06-30,2014-08-05 06:52:44+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,3456078000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1,,2014-03-31,2014-05-08 06:57:11+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,461858000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1,,2014-03-31,2014-05-08 06:57:11+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,186275000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1,,2014-03-31,2014-05-08 06:57:11+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,1047496000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1,,2014-03-31,2014-05-08 06:57:11+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,86545000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1,,2014-03-31,2014-05-08 06:57:11+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,52252000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1,,2014-03-31,2014-05-08 06:57:11+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,36623000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1,,2014-03-31,2014-05-08 06:57:11+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,1871049000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1,,2014-03-31,2014-05-08 06:57:11+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,600864000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1,,2014-03-31,2014-05-08 06:57:11+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,534689000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1,,2014-03-31,2014-05-08 06:57:11+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,248454000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1,,2014-03-31,2014-05-08 06:57:11+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,5340000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1,,2014-03-31,2014-05-08 06:57:11+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,788483000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1,,2014-03-31,2014-05-08 06:57:11+00:00,,totalassets,Total Assets,=,debit,usd,3260396000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1,,2014-03-31,2014-05-08 06:57:11+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,1060000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1,,2014-03-31,2014-05-08 06:57:11+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,237935000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1,,2014-03-31,2014-05-08 06:57:11+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,66073000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1,,2014-03-31,2014-05-08 06:57:11+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,305068000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1,,2014-03-31,2014-05-08 06:57:11+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,326673000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1,,2014-03-31,2014-05-08 06:57:11+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,203380000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1,,2014-03-31,2014-05-08 06:57:11+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,202233000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1,,2014-03-31,2014-05-08 06:57:11+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,11794000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1,,2014-03-31,2014-05-08 06:57:11+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,744080000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1,,2014-03-31,2014-05-08 06:57:11+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,1049148000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1,,2014-03-31,2014-05-08 06:57:11+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1,,2014-03-31,2014-05-08 06:57:11+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,2237032000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1,,2014-03-31,2014-05-08 06:57:11+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-27249000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1,,2014-03-31,2014-05-08 06:57:11+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,1465000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1,,2014-03-31,2014-05-08 06:57:11+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,2211248000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1,,2014-03-31,2014-05-08 06:57:11+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,2211248000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1,,2014-03-31,2014-05-08 06:57:11+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,2211248000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1,,2014-03-31,2014-05-08 06:57:11+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,3260396000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,FY,,2015-12-31,2017-02-09 16:05:36+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,809102000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,FY,,2015-12-31,2017-02-09 16:05:36+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,236121000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,FY,,2015-12-31,2017-02-09 16:05:36+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,1467793000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,FY,,2015-12-31,2017-02-09 16:05:36+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,238578000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,FY,,2015-12-31,2017-02-09 16:05:36+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,163501000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,FY,,2015-12-31,2017-02-09 16:05:36+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,2915095000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,FY,,2015-12-31,2017-02-09 16:05:36+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1594120000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,FY,,2015-12-31,2017-02-09 16:05:36+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,632162000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,FY,,2015-12-31,2017-02-09 16:05:36+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,461945000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,FY,,2015-12-31,2017-02-09 16:05:36+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,5810000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,FY,,2015-12-31,2017-02-09 16:05:36+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,1099917000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,FY,,2015-12-31,2017-02-09 16:05:36+00:00,,totalassets,Total Assets,=,debit,usd,5609132000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,FY,,2015-12-31,2017-02-09 16:05:36+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,FY,,2015-12-31,2017-02-09 16:05:36+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,644112000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,FY,,2015-12-31,2017-02-09 16:05:36+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,153487000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,FY,,2015-12-31,2017-02-09 16:05:36+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,13563000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,FY,,2015-12-31,2017-02-09 16:05:36+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,811162000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,FY,,2015-12-31,2017-02-09 16:05:36+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,362919000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,FY,,2015-12-31,2017-02-09 16:05:36+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,664679000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,FY,,2015-12-31,2017-02-09 16:05:36+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,115535000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,FY,,2015-12-31,2017-02-09 16:05:36+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,1143133000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,FY,,2015-12-31,2017-02-09 16:05:36+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,1954295000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,FY,,2015-12-31,2017-02-09 16:05:36+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,FY,,2015-12-31,2017-02-09 16:05:36+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,FY,,2015-12-31,2017-02-09 16:05:36+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,3099526000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,FY,,2015-12-31,2017-02-09 16:05:36+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,852700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,FY,,2015-12-31,2017-02-09 16:05:36+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-306069000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,FY,,2015-12-31,2017-02-09 16:05:36+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,8572000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,FY,,2015-12-31,2017-02-09 16:05:36+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,3654729000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,FY,,2015-12-31,2017-02-09 16:05:36+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,3654837000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,FY,,2015-12-31,2017-02-09 16:05:36+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,3654837000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,FY,,2015-12-31,2017-02-09 16:05:36+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,5609132000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3,,2015-09-30,2015-11-04 07:24:05+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,654587000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3,,2015-09-30,2015-11-04 07:24:05+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,241055000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3,,2015-09-30,2015-11-04 07:24:05+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,1439315000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3,,2015-09-30,2015-11-04 07:24:05+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,190668000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3,,2015-09-30,2015-11-04 07:24:05+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,89494000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3,,2015-09-30,2015-11-04 07:24:05+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,60521000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3,,2015-09-30,2015-11-04 07:24:05+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,2675640000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3,,2015-09-30,2015-11-04 07:24:05+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1475123000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3,,2015-09-30,2015-11-04 07:24:05+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,681326000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3,,2015-09-30,2015-11-04 07:24:05+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,346243000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3,,2015-09-30,2015-11-04 07:24:05+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,4583000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3,,2015-09-30,2015-11-04 07:24:05+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,1032152000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3,,2015-09-30,2015-11-04 07:24:05+00:00,,totalassets,Total Assets,=,debit,usd,5182915000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3,,2015-09-30,2015-11-04 07:24:05+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,577428000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3,,2015-09-30,2015-11-04 07:24:05+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,155056000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3,,2015-09-30,2015-11-04 07:24:05+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,2506000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3,,2015-09-30,2015-11-04 07:24:05+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,734990000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3,,2015-09-30,2015-11-04 07:24:05+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,30723000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3,,2015-09-30,2015-11-04 07:24:05+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,364144000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3,,2015-09-30,2015-11-04 07:24:05+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,678281000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3,,2015-09-30,2015-11-04 07:24:05+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,77910000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3,,2015-09-30,2015-11-04 07:24:05+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,1151058000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3,,2015-09-30,2015-11-04 07:24:05+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,1886048000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3,,2015-09-30,2015-11-04 07:24:05+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3,,2015-09-30,2015-11-04 07:24:05+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,2880109000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3,,2015-09-30,2015-11-04 07:24:05+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,697706000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3,,2015-09-30,2015-11-04 07:24:05+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-288777000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3,,2015-09-30,2015-11-04 07:24:05+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,7721000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3,,2015-09-30,2015-11-04 07:24:05+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,3296759000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3,,2015-09-30,2015-11-04 07:24:05+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,3296867000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3,,2015-09-30,2015-11-04 07:24:05+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,3296867000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3,,2015-09-30,2015-11-04 07:24:05+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,5182915000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2,,2015-06-30,2015-08-04 07:21:24+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,390554000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2,,2015-06-30,2015-08-04 07:21:24+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,213694000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2,,2015-06-30,2015-08-04 07:21:24+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,1395125000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2,,2015-06-30,2015-08-04 07:21:24+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,171266000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2,,2015-06-30,2015-08-04 07:21:24+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,43099000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2,,2015-06-30,2015-08-04 07:21:24+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,69603000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2,,2015-06-30,2015-08-04 07:21:24+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,2283341000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2,,2015-06-30,2015-08-04 07:21:24+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1326112000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2,,2015-06-30,2015-08-04 07:21:24+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,589595000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2,,2015-06-30,2015-08-04 07:21:24+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,323784000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2,,2015-06-30,2015-08-04 07:21:24+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,4138000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2,,2015-06-30,2015-08-04 07:21:24+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,917517000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2,,2015-06-30,2015-08-04 07:21:24+00:00,,totalassets,Total Assets,=,debit,usd,4526970000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2,,2015-06-30,2015-08-04 07:21:24+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,529505000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2,,2015-06-30,2015-08-04 07:21:24+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,69746000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2,,2015-06-30,2015-08-04 07:21:24+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,2291000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2,,2015-06-30,2015-08-04 07:21:24+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,601542000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2,,2015-06-30,2015-08-04 07:21:24+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,30360000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2,,2015-06-30,2015-08-04 07:21:24+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,357687000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2,,2015-06-30,2015-08-04 07:21:24+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,122843000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2,,2015-06-30,2015-08-04 07:21:24+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,76080000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2,,2015-06-30,2015-08-04 07:21:24+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,586970000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2,,2015-06-30,2015-08-04 07:21:24+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,1188512000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2,,2015-06-30,2015-08-04 07:21:24+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2,,2015-06-30,2015-08-04 07:21:24+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,3118969000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2,,2015-06-30,2015-08-04 07:21:24+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,487308000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2,,2015-06-30,2015-08-04 07:21:24+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-287079000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2,,2015-06-30,2015-08-04 07:21:24+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,19153000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2,,2015-06-30,2015-08-04 07:21:24+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,3338351000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2,,2015-06-30,2015-08-04 07:21:24+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,3338458000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2,,2015-06-30,2015-08-04 07:21:24+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,3338458000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2,,2015-06-30,2015-08-04 07:21:24+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,4526970000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1,,2015-03-31,2015-05-07 07:30:44+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,507907000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1,,2015-03-31,2015-05-07 07:30:44+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,234257000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1,,2015-03-31,2015-05-07 07:30:44+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,1338462000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1,,2015-03-31,2015-05-07 07:30:44+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,133863000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1,,2015-03-31,2015-05-07 07:30:44+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,34099000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1,,2015-03-31,2015-05-07 07:30:44+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,62126000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1,,2015-03-31,2015-05-07 07:30:44+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,2310714000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1,,2015-03-31,2015-05-07 07:30:44+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1110597000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1,,2015-03-31,2015-05-07 07:30:44+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,483305000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1,,2015-03-31,2015-05-07 07:30:44+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,289484000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1,,2015-03-31,2015-05-07 07:30:44+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,4473000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1,,2015-03-31,2015-05-07 07:30:44+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,777262000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1,,2015-03-31,2015-05-07 07:30:44+00:00,,totalassets,Total Assets,=,debit,usd,4198573000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1,,2015-03-31,2015-05-07 07:30:44+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,462762000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1,,2015-03-31,2015-05-07 07:30:44+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,71187000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1,,2015-03-31,2015-05-07 07:30:44+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,2185000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1,,2015-03-31,2015-05-07 07:30:44+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,536134000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1,,2015-03-31,2015-05-07 07:30:44+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,144082000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1,,2015-03-31,2015-05-07 07:30:44+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,328394000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1,,2015-03-31,2015-05-07 07:30:44+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,162974000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1,,2015-03-31,2015-05-07 07:30:44+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,55559000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1,,2015-03-31,2015-05-07 07:30:44+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,691009000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1,,2015-03-31,2015-05-07 07:30:44+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,1227143000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1,,2015-03-31,2015-05-07 07:30:44+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1,,2015-03-31,2015-05-07 07:30:44+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,2812573000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1,,2015-03-31,2015-05-07 07:30:44+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,292665000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1,,2015-03-31,2015-05-07 07:30:44+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-181817000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1,,2015-03-31,2015-05-07 07:30:44+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,47904000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1,,2015-03-31,2015-05-07 07:30:44+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,2971325000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1,,2015-03-31,2015-05-07 07:30:44+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,2971430000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1,,2015-03-31,2015-05-07 07:30:44+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,2971430000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1,,2015-03-31,2015-05-07 07:30:44+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,4198573000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,FY,,2016-12-31,2018-02-08 16:22:58+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,535203000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,FY,,2016-12-31,2018-02-08 16:22:58+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,503481000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,FY,,2016-12-31,2018-02-08 16:22:58+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,1611620000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,FY,,2016-12-31,2018-02-08 16:22:58+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,399356000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,FY,,2016-12-31,2018-02-08 16:22:58+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,130528000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,FY,,2016-12-31,2018-02-08 16:22:58+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,3180188000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,FY,,2016-12-31,2018-02-08 16:22:58+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2083421000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,FY,,2016-12-31,2018-02-08 16:22:58+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,864260000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,FY,,2016-12-31,2018-02-08 16:22:58+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,825303000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,FY,,2016-12-31,2018-02-08 16:22:58+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,20294000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,FY,,2016-12-31,2018-02-08 16:22:58+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,1709857000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,FY,,2016-12-31,2018-02-08 16:22:58+00:00,,totalassets,Total Assets,=,debit,usd,6973466000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,FY,,2016-12-31,2018-02-08 16:22:58+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,129557000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,FY,,2016-12-31,2018-02-08 16:22:58+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,879096000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,FY,,2016-12-31,2018-02-08 16:22:58+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,231664000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,FY,,2016-12-31,2018-02-08 16:22:58+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,1178000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,FY,,2016-12-31,2018-02-08 16:22:58+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,1241495000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,FY,,2016-12-31,2018-02-08 16:22:58+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,351569000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,FY,,2016-12-31,2018-02-08 16:22:58+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,830772000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,FY,,2016-12-31,2018-02-08 16:22:58+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,100385000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,FY,,2016-12-31,2018-02-08 16:22:58+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,1282726000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,FY,,2016-12-31,2018-02-08 16:22:58+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,2524221000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,FY,,2016-12-31,2018-02-08 16:22:58+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,FY,,2016-12-31,2018-02-08 16:22:58+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,FY,,2016-12-31,2018-02-08 16:22:58+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,3029993000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,FY,,2016-12-31,2018-02-08 16:22:58+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,1748222000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,FY,,2016-12-31,2018-02-08 16:22:58+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-316240000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,FY,,2016-12-31,2018-02-08 16:22:58+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-12840000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,FY,,2016-12-31,2018-02-08 16:22:58+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,4449135000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,FY,,2016-12-31,2018-02-08 16:22:58+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,4449245000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,FY,,2016-12-31,2018-02-08 16:22:58+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,4449245000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,FY,,2016-12-31,2018-02-08 16:22:58+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,6973466000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3,,2016-09-30,2016-11-04 07:32:27+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,920359000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3,,2016-09-30,2016-11-04 07:32:27+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,488032000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3,,2016-09-30,2016-11-04 07:32:27+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,1643872000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3,,2016-09-30,2016-11-04 07:32:27+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,345620000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3,,2016-09-30,2016-11-04 07:32:27+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,103806000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3,,2016-09-30,2016-11-04 07:32:27+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,3501689000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3,,2016-09-30,2016-11-04 07:32:27+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1872167000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3,,2016-09-30,2016-11-04 07:32:27+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,777906000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3,,2016-09-30,2016-11-04 07:32:27+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,655552000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3,,2016-09-30,2016-11-04 07:32:27+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,20705000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3,,2016-09-30,2016-11-04 07:32:27+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,1454163000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3,,2016-09-30,2016-11-04 07:32:27+00:00,,totalassets,Total Assets,=,debit,usd,6828019000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3,,2016-09-30,2016-11-04 07:32:27+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,714916000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3,,2016-09-30,2016-11-04 07:32:27+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,242683000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3,,2016-09-30,2016-11-04 07:32:27+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,3586000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3,,2016-09-30,2016-11-04 07:32:27+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,961185000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3,,2016-09-30,2016-11-04 07:32:27+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,382228000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3,,2016-09-30,2016-11-04 07:32:27+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,857659000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3,,2016-09-30,2016-11-04 07:32:27+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,135700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3,,2016-09-30,2016-11-04 07:32:27+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,1375587000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3,,2016-09-30,2016-11-04 07:32:27+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,2336772000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3,,2016-09-30,2016-11-04 07:32:27+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3,,2016-09-30,2016-11-04 07:32:27+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,3314982000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3,,2016-09-30,2016-11-04 07:32:27+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,1495107000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3,,2016-09-30,2016-11-04 07:32:27+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-316052000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3,,2016-09-30,2016-11-04 07:32:27+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-2899000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3,,2016-09-30,2016-11-04 07:32:27+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,4491138000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3,,2016-09-30,2016-11-04 07:32:27+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,4491247000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3,,2016-09-30,2016-11-04 07:32:27+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,4491247000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3,,2016-09-30,2016-11-04 07:32:27+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,6828019000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2,,2016-06-30,2016-08-04 07:31:35+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,646508000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2,,2016-06-30,2016-08-04 07:31:35+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,398656000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2,,2016-06-30,2016-08-04 07:31:35+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,1751971000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2,,2016-06-30,2016-08-04 07:31:35+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,316073000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2,,2016-06-30,2016-08-04 07:31:35+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,96017000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2,,2016-06-30,2016-08-04 07:31:35+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,3209225000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2,,2016-06-30,2016-08-04 07:31:35+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1772923000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2,,2016-06-30,2016-08-04 07:31:35+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,589852000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2,,2016-06-30,2016-08-04 07:31:35+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,626191000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2,,2016-06-30,2016-08-04 07:31:35+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,6715000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2,,2016-06-30,2016-08-04 07:31:35+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,1222758000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2,,2016-06-30,2016-08-04 07:31:35+00:00,,totalassets,Total Assets,=,debit,usd,6204906000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2,,2016-06-30,2016-08-04 07:31:35+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,759643000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2,,2016-06-30,2016-08-04 07:31:35+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,188225000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2,,2016-06-30,2016-08-04 07:31:35+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,3695000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2,,2016-06-30,2016-08-04 07:31:35+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,951563000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2,,2016-06-30,2016-08-04 07:31:35+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,361523000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2,,2016-06-30,2016-08-04 07:31:35+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,695791000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2,,2016-06-30,2016-08-04 07:31:35+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,119523000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2,,2016-06-30,2016-08-04 07:31:35+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,1176837000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2,,2016-06-30,2016-08-04 07:31:35+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,2128400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2,,2016-06-30,2016-08-04 07:31:35+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2,,2016-06-30,2016-08-04 07:31:35+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,3156942000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2,,2016-06-30,2016-08-04 07:31:35+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,1230303000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2,,2016-06-30,2016-08-04 07:31:35+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-316052000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2,,2016-06-30,2016-08-04 07:31:35+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,5204000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2,,2016-06-30,2016-08-04 07:31:35+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,4076397000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2,,2016-06-30,2016-08-04 07:31:35+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,4076506000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2,,2016-06-30,2016-08-04 07:31:35+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,4076506000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2,,2016-06-30,2016-08-04 07:31:35+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,6204906000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1,,2016-03-31,2016-05-05 07:35:22+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,604214000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1,,2016-03-31,2016-05-05 07:35:22+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,244965000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1,,2016-03-31,2016-05-05 07:35:22+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,1865221000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1,,2016-03-31,2016-05-05 07:35:22+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,303294000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1,,2016-03-31,2016-05-05 07:35:22+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,115685000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1,,2016-03-31,2016-05-05 07:35:22+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,3133379000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1,,2016-03-31,2016-05-05 07:35:22+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1666391000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1,,2016-03-31,2016-05-05 07:35:22+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,555210000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1,,2016-03-31,2016-05-05 07:35:22+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,543689000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1,,2016-03-31,2016-05-05 07:35:22+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,5791000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1,,2016-03-31,2016-05-05 07:35:22+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,1104690000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1,,2016-03-31,2016-05-05 07:35:22+00:00,,totalassets,Total Assets,=,debit,usd,5904460000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1,,2016-03-31,2016-05-05 07:35:22+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,733276000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1,,2016-03-31,2016-05-05 07:35:22+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,172940000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1,,2016-03-31,2016-05-05 07:35:22+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,13508000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1,,2016-03-31,2016-05-05 07:35:22+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,919724000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1,,2016-03-31,2016-05-05 07:35:22+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,362230000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1,,2016-03-31,2016-05-05 07:35:22+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,736431000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1,,2016-03-31,2016-05-05 07:35:22+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,120993000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1,,2016-03-31,2016-05-05 07:35:22+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,1219654000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1,,2016-03-31,2016-05-05 07:35:22+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,2139378000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1,,2016-03-31,2016-05-05 07:35:22+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1,,2016-03-31,2016-05-05 07:35:22+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,3049651000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1,,2016-03-31,2016-05-05 07:35:22+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,1018436000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1,,2016-03-31,2016-05-05 07:35:22+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-307478000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1,,2016-03-31,2016-05-05 07:35:22+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,4364000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1,,2016-03-31,2016-05-05 07:35:22+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,3764973000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1,,2016-03-31,2016-05-05 07:35:22+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,3765082000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1,,2016-03-31,2016-05-05 07:35:22+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,3765082000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1,,2016-03-31,2016-05-05 07:35:22+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,5904460000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,FY,,2017-12-31,2018-08-02 16:11:08+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,812733000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,FY,,2017-12-31,2018-08-02 16:11:08+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,596847000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,FY,,2017-12-31,2018-08-02 16:11:08+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,1974340000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,FY,,2017-12-31,2018-08-02 16:11:08+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,726138000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,FY,,2017-12-31,2018-08-02 16:11:08+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,224972000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,FY,,2017-12-31,2018-08-02 16:11:08+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,4335030000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,FY,,2017-12-31,2018-08-02 16:11:08+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2358605000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,FY,,2017-12-31,2018-08-02 16:11:08+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,1486494000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,FY,,2017-12-31,2018-08-02 16:11:08+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,506291000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,FY,,2017-12-31,2018-08-02 16:11:08+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,77866000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,FY,,2017-12-31,2018-08-02 16:11:08+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,2070651000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,FY,,2017-12-31,2018-08-02 16:11:08+00:00,,totalassets,Total Assets,=,debit,usd,8764286000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,FY,,2017-12-31,2018-08-02 16:11:08+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,178183000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,FY,,2017-12-31,2018-08-02 16:11:08+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,637162000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,FY,,2017-12-31,2018-08-02 16:11:08+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,320138000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,FY,,2017-12-31,2018-08-02 16:11:08+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,1135483000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,FY,,2017-12-31,2018-08-02 16:11:08+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,703453000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,FY,,2017-12-31,2018-08-02 16:11:08+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,629199000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,FY,,2017-12-31,2018-08-02 16:11:08+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,152073000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,FY,,2017-12-31,2018-08-02 16:11:08+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,1484725000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,FY,,2017-12-31,2018-08-02 16:11:08+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,2620208000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,FY,,2017-12-31,2018-08-02 16:11:08+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,FY,,2017-12-31,2018-08-02 16:11:08+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,3512833000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,FY,,2017-12-31,2018-08-02 16:11:08+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,2946733000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,FY,,2017-12-31,2018-08-02 16:11:08+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-316240000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,FY,,2017-12-31,2018-08-02 16:11:08+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,640000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,FY,,2017-12-31,2018-08-02 16:11:08+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,6143966000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,FY,,2017-12-31,2018-08-02 16:11:08+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,6144078000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,FY,,2017-12-31,2018-08-02 16:11:08+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,6144078000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,FY,,2017-12-31,2018-08-02 16:11:08+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,8764286000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3,,2017-09-30,2017-11-08 07:54:13+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,792065000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3,,2017-09-30,2017-11-08 07:54:13+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,586879000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3,,2017-09-30,2017-11-08 07:54:13+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,1971449000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3,,2017-09-30,2017-11-08 07:54:13+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,641588000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3,,2017-09-30,2017-11-08 07:54:13+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,143761000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3,,2017-09-30,2017-11-08 07:54:13+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,4135742000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3,,2017-09-30,2017-11-08 07:54:13+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2274529000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3,,2017-09-30,2017-11-08 07:54:13+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,1327303000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3,,2017-09-30,2017-11-08 07:54:13+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,927023000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3,,2017-09-30,2017-11-08 07:54:13+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,36618000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3,,2017-09-30,2017-11-08 07:54:13+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,2290944000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3,,2017-09-30,2017-11-08 07:54:13+00:00,,totalassets,Total Assets,=,debit,usd,8701215000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3,,2017-09-30,2017-11-08 07:54:13+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3,,2017-09-30,2017-11-08 07:54:13+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,818426000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3,,2017-09-30,2017-11-08 07:54:13+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,319868000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3,,2017-09-30,2017-11-08 07:54:13+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,334000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3,,2017-09-30,2017-11-08 07:54:13+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,1138628000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3,,2017-09-30,2017-11-08 07:54:13+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,702317000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3,,2017-09-30,2017-11-08 07:54:13+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,683452000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3,,2017-09-30,2017-11-08 07:54:13+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,125225000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3,,2017-09-30,2017-11-08 07:54:13+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,1510994000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3,,2017-09-30,2017-11-08 07:54:13+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,2649622000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3,,2017-09-30,2017-11-08 07:54:13+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3,,2017-09-30,2017-11-08 07:54:13+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,3570673000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3,,2017-09-30,2017-11-08 07:54:13+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,2773214000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3,,2017-09-30,2017-11-08 07:54:13+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-316240000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3,,2017-09-30,2017-11-08 07:54:13+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,23835000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3,,2017-09-30,2017-11-08 07:54:13+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,6051482000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3,,2017-09-30,2017-11-08 07:54:13+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,6051593000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3,,2017-09-30,2017-11-08 07:54:13+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,6051593000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3,,2017-09-30,2017-11-08 07:54:13+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,8701215000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2,,2017-06-30,2017-08-03 07:46:53+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,744313000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2,,2017-06-30,2017-08-03 07:46:53+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,523537000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2,,2017-06-30,2017-08-03 07:46:53+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,1844547000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2,,2017-06-30,2017-08-03 07:46:53+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,554320000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2,,2017-06-30,2017-08-03 07:46:53+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,193334000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2,,2017-06-30,2017-08-03 07:46:53+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,3860051000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2,,2017-06-30,2017-08-03 07:46:53+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2261702000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2,,2017-06-30,2017-08-03 07:46:53+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,1064677000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2,,2017-06-30,2017-08-03 07:46:53+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,882980000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2,,2017-06-30,2017-08-03 07:46:53+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,36963000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2,,2017-06-30,2017-08-03 07:46:53+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,1984620000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2,,2017-06-30,2017-08-03 07:46:53+00:00,,totalassets,Total Assets,=,debit,usd,8106373000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2,,2017-06-30,2017-08-03 07:46:53+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2,,2017-06-30,2017-08-03 07:46:53+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,716364000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2,,2017-06-30,2017-08-03 07:46:53+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,312256000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2,,2017-06-30,2017-08-03 07:46:53+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,397000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2,,2017-06-30,2017-08-03 07:46:53+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,1029017000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2,,2017-06-30,2017-08-03 07:46:53+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,701173000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2,,2017-06-30,2017-08-03 07:46:53+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,739525000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2,,2017-06-30,2017-08-03 07:46:53+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,115920000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2,,2017-06-30,2017-08-03 07:46:53+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,1556618000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2,,2017-06-30,2017-08-03 07:46:53+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,2585635000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2,,2017-06-30,2017-08-03 07:46:53+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2,,2017-06-30,2017-08-03 07:46:53+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,3449622000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2,,2017-06-30,2017-08-03 07:46:53+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,2384897000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2,,2017-06-30,2017-08-03 07:46:53+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-316240000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2,,2017-06-30,2017-08-03 07:46:53+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,2348000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2,,2017-06-30,2017-08-03 07:46:53+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,5520627000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2,,2017-06-30,2017-08-03 07:46:53+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,5520738000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2,,2017-06-30,2017-08-03 07:46:53+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,5520738000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2,,2017-06-30,2017-08-03 07:46:53+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,8106373000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1,,2017-03-31,2017-05-04 07:43:33+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,811773000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1,,2017-03-31,2017-05-04 07:43:33+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,495311000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1,,2017-03-31,2017-05-04 07:43:33+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,1749548000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1,,2017-03-31,2017-05-04 07:43:33+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,466576000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1,,2017-03-31,2017-05-04 07:43:33+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,146055000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1,,2017-03-31,2017-05-04 07:43:33+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,3669263000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1,,2017-03-31,2017-05-04 07:43:33+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2277029000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1,,2017-03-31,2017-05-04 07:43:33+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,967695000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1,,2017-03-31,2017-05-04 07:43:33+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,866291000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1,,2017-03-31,2017-05-04 07:43:33+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,37087000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1,,2017-03-31,2017-05-04 07:43:33+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,1871073000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1,,2017-03-31,2017-05-04 07:43:33+00:00,,totalassets,Total Assets,=,debit,usd,7817365000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1,,2017-03-31,2017-05-04 07:43:33+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,7200000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1,,2017-03-31,2017-05-04 07:43:33+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1061777000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1,,2017-03-31,2017-05-04 07:43:33+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,238418000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1,,2017-03-31,2017-05-04 07:43:33+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,876000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1,,2017-03-31,2017-05-04 07:43:33+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,1308271000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1,,2017-03-31,2017-05-04 07:43:33+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,700407000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1,,2017-03-31,2017-05-04 07:43:33+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,836418000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1,,2017-03-31,2017-05-04 07:43:33+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,106248000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1,,2017-03-31,2017-05-04 07:43:33+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,1643073000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1,,2017-03-31,2017-05-04 07:43:33+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,2951344000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1,,2017-03-31,2017-05-04 07:43:33+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1,,2017-03-31,2017-05-04 07:43:33+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,3190882000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1,,2017-03-31,2017-05-04 07:43:33+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,1997153000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1,,2017-03-31,2017-05-04 07:43:33+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-316240000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1,,2017-03-31,2017-05-04 07:43:33+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-5884000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1,,2017-03-31,2017-05-04 07:43:33+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,4865911000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1,,2017-03-31,2017-05-04 07:43:33+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,4866021000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1,,2017-03-31,2017-05-04 07:43:33+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,4866021000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1,,2017-03-31,2017-05-04 07:43:33+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,7817365000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,FY,,2018-12-31,2020-02-07 09:04:34+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,1467700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,FY,,2018-12-31,2020-02-07 09:04:34+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,1342200000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,FY,,2018-12-31,2020-02-07 09:04:34+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,2243200000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,FY,,2018-12-31,2020-02-07 09:04:34+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,1151200000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,FY,,2018-12-31,2020-02-07 09:04:34+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,243300000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,FY,,2018-12-31,2020-02-07 09:04:34+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,6447600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,FY,,2018-12-31,2020-02-07 09:04:34+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2575800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,FY,,2018-12-31,2020-02-07 09:04:34+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,1755000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,FY,,2018-12-31,2020-02-07 09:04:34+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,828700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,FY,,2018-12-31,2020-02-07 09:04:34+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,127400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,FY,,2018-12-31,2020-02-07 09:04:34+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,2711100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,FY,,2018-12-31,2020-02-07 09:04:34+00:00,,totalassets,Total Assets,=,debit,usd,11734500000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,FY,,2018-12-31,2020-02-07 09:04:34+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,218200000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,FY,,2018-12-31,2020-02-07 09:04:34+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,772100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,FY,,2018-12-31,2020-02-07 09:04:34+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,452500000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,FY,,2018-12-31,2020-02-07 09:04:34+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,1442800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,FY,,2018-12-31,2020-02-07 09:04:34+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,708500000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,FY,,2018-12-31,2020-02-07 09:04:34+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,464200000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,FY,,2018-12-31,2020-02-07 09:04:34+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,361700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,FY,,2018-12-31,2020-02-07 09:04:34+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,1534400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,FY,,2018-12-31,2020-02-07 09:04:34+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,2977200000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,FY,,2018-12-31,2020-02-07 09:04:34+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,FY,,2018-12-31,2020-02-07 09:04:34+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,FY,,2018-12-31,2020-02-07 09:04:34+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,3911600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,FY,,2018-12-31,2020-02-07 09:04:34+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,5254300000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,FY,,2018-12-31,2020-02-07 09:04:34+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-396400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,FY,,2018-12-31,2020-02-07 09:04:34+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-12300000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,FY,,2018-12-31,2020-02-07 09:04:34+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,8757200000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,FY,,2018-12-31,2020-02-07 09:04:34+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,8757300000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,FY,,2018-12-31,2020-02-07 09:04:34+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,8757300000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,FY,,2018-12-31,2020-02-07 09:04:34+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,11734500000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3,,2018-09-30,2018-11-06 07:56:51+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,1087843000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3,,2018-09-30,2018-11-06 07:56:51+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,1104309000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3,,2018-09-30,2018-11-06 07:56:51+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,2202945000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3,,2018-09-30,2018-11-06 07:56:51+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,1039679000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3,,2018-09-30,2018-11-06 07:56:51+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,284807000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3,,2018-09-30,2018-11-06 07:56:51+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,5719583000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3,,2018-09-30,2018-11-06 07:56:51+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2524446000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3,,2018-09-30,2018-11-06 07:56:51+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,1873569000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3,,2018-09-30,2018-11-06 07:56:51+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,562818000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3,,2018-09-30,2018-11-06 07:56:51+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,125197000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3,,2018-09-30,2018-11-06 07:56:51+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,2561584000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3,,2018-09-30,2018-11-06 07:56:51+00:00,,totalassets,Total Assets,=,debit,usd,10805613000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3,,2018-09-30,2018-11-06 07:56:51+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,172361000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3,,2018-09-30,2018-11-06 07:56:51+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,781924000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3,,2018-09-30,2018-11-06 07:56:51+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,462945000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3,,2018-09-30,2018-11-06 07:56:51+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,1417230000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3,,2018-09-30,2018-11-06 07:56:51+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,707203000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3,,2018-09-30,2018-11-06 07:56:51+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,618847000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3,,2018-09-30,2018-11-06 07:56:51+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,194033000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3,,2018-09-30,2018-11-06 07:56:51+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,1520083000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3,,2018-09-30,2018-11-06 07:56:51+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,2937313000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3,,2018-09-30,2018-11-06 07:56:51+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3,,2018-09-30,2018-11-06 07:56:51+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,3841174000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3,,2018-09-30,2018-11-06 07:56:51+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,4433904000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3,,2018-09-30,2018-11-06 07:56:51+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-396371000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3,,2018-09-30,2018-11-06 07:56:51+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-10519000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3,,2018-09-30,2018-11-06 07:56:51+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,7868188000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3,,2018-09-30,2018-11-06 07:56:51+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,7868300000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3,,2018-09-30,2018-11-06 07:56:51+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,7868300000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3,,2018-09-30,2018-11-06 07:56:51+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,10805613000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2,,2018-06-30,2018-08-02 16:11:08+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,917876000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2,,2018-06-30,2018-08-02 16:11:08+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,765642000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2,,2018-06-30,2018-08-02 16:11:08+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,2039247000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2,,2018-06-30,2018-08-02 16:11:08+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,928553000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2,,2018-06-30,2018-08-02 16:11:08+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,163599000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2,,2018-06-30,2018-08-02 16:11:08+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,4814917000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2,,2018-06-30,2018-08-02 16:11:08+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2461614000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2,,2018-06-30,2018-08-02 16:11:08+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,2044703000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2,,2018-06-30,2018-08-02 16:11:08+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,545077000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2,,2018-06-30,2018-08-02 16:11:08+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,85669000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2,,2018-06-30,2018-08-02 16:11:08+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,2675449000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2,,2018-06-30,2018-08-02 16:11:08+00:00,,totalassets,Total Assets,=,debit,usd,9951980000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2,,2018-06-30,2018-08-02 16:11:08+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,171906000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2,,2018-06-30,2018-08-02 16:11:08+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,670709000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2,,2018-06-30,2018-08-02 16:11:08+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,488575000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2,,2018-06-30,2018-08-02 16:11:08+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,1331190000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2,,2018-06-30,2018-08-02 16:11:08+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,705903000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2,,2018-06-30,2018-08-02 16:11:08+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,538441000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2,,2018-06-30,2018-08-02 16:11:08+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,190020000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2,,2018-06-30,2018-08-02 16:11:08+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,1434364000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2,,2018-06-30,2018-08-02 16:11:08+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,2765554000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2,,2018-06-30,2018-08-02 16:11:08+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2,,2018-06-30,2018-08-02 16:11:08+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,3712599000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2,,2018-06-30,2018-08-02 16:11:08+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,3839179000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2,,2018-06-30,2018-08-02 16:11:08+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-353852000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2,,2018-06-30,2018-08-02 16:11:08+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-11612000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2,,2018-06-30,2018-08-02 16:11:08+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,7186314000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2,,2018-06-30,2018-08-02 16:11:08+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,7186426000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2,,2018-06-30,2018-08-02 16:11:08+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,7186426000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2,,2018-06-30,2018-08-02 16:11:08+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,9951980000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1,,2018-03-31,2018-05-03 16:02:59+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,1019491000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1,,2018-03-31,2018-05-03 16:02:59+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,605461000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1,,2018-03-31,2018-05-03 16:02:59+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,1943932000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1,,2018-03-31,2018-05-03 16:02:59+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,820397000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1,,2018-03-31,2018-05-03 16:02:59+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,155451000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1,,2018-03-31,2018-05-03 16:02:59+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,4544732000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1,,2018-03-31,2018-05-03 16:02:59+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2394727000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1,,2018-03-31,2018-05-03 16:02:59+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,1821985000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1,,2018-03-31,2018-05-03 16:02:59+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,532268000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1,,2018-03-31,2018-05-03 16:02:59+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,78984000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1,,2018-03-31,2018-05-03 16:02:59+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,2433237000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1,,2018-03-31,2018-05-03 16:02:59+00:00,,totalassets,Total Assets,=,debit,usd,9372696000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1,,2018-03-31,2018-05-03 16:02:59+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,207611000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1,,2018-03-31,2018-05-03 16:02:59+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,666216000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1,,2018-03-31,2018-05-03 16:02:59+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,391913000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1,,2018-03-31,2018-05-03 16:02:59+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,1265740000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1,,2018-03-31,2018-05-03 16:02:59+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,704645000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1,,2018-03-31,2018-05-03 16:02:59+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,664745000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1,,2018-03-31,2018-05-03 16:02:59+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,169922000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1,,2018-03-31,2018-05-03 16:02:59+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,1539312000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1,,2018-03-31,2018-05-03 16:02:59+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,2805052000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1,,2018-03-31,2018-05-03 16:02:59+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1,,2018-03-31,2018-05-03 16:02:59+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,3611599000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1,,2018-03-31,2018-05-03 16:02:59+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,3287767000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1,,2018-03-31,2018-05-03 16:02:59+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-316240000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1,,2018-03-31,2018-05-03 16:02:59+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-15594000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1,,2018-03-31,2018-05-03 16:02:59+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,6567532000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1,,2018-03-31,2018-05-03 16:02:59+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,6567644000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1,,2018-03-31,2018-05-03 16:02:59+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,6567644000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1,,2018-03-31,2018-05-03 16:02:59+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,9372696000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,FY,,2019-12-31,2020-05-05 07:51:29+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,1617800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,FY,,2019-12-31,2020-05-05 07:51:29+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,1596500000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,FY,,2019-12-31,2020-05-05 07:51:29+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,2785600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,FY,,2019-12-31,2020-05-05 07:51:29+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,1415500000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,FY,,2019-12-31,2020-05-05 07:51:29+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,273700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,FY,,2019-12-31,2020-05-05 07:51:29+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,7689100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,FY,,2019-12-31,2020-05-05 07:51:29+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2890400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,FY,,2019-12-31,2020-05-05 07:51:29+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,3256800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,FY,,2019-12-31,2020-05-05 07:51:29+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,824200000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,FY,,2019-12-31,2020-05-05 07:51:29+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,144700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,FY,,2019-12-31,2020-05-05 07:51:29+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,4225700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,FY,,2019-12-31,2020-05-05 07:51:29+00:00,,totalassets,Total Assets,=,debit,usd,14805200000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,FY,,2019-12-31,2020-05-05 07:51:29+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,418100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,FY,,2019-12-31,2020-05-05 07:51:29+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,1211400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,FY,,2019-12-31,2020-05-05 07:51:29+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,382100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,FY,,2019-12-31,2020-05-05 07:51:29+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,85000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,FY,,2019-12-31,2020-05-05 07:51:29+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,2096600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,FY,,2019-12-31,2020-05-05 07:51:29+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,713900000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,FY,,2019-12-31,2020-05-05 07:51:29+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,105300000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,FY,,2019-12-31,2020-05-05 07:51:29+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,799700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,FY,,2019-12-31,2020-05-05 07:51:29+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,1618900000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,FY,,2019-12-31,2020-05-05 07:51:29+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,3715500000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,FY,,2019-12-31,2020-05-05 07:51:29+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,FY,,2019-12-31,2020-05-05 07:51:29+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,4428600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,FY,,2019-12-31,2020-05-05 07:51:29+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,7379800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,FY,,2019-12-31,2020-05-05 07:51:29+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-739900000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,FY,,2019-12-31,2020-05-05 07:51:29+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,21100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,FY,,2019-12-31,2020-05-05 07:51:29+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,11089600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,FY,,2019-12-31,2020-05-05 07:51:29+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,11089700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,FY,,2019-12-31,2020-05-05 07:51:29+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,11089700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,FY,,2019-12-31,2020-05-05 07:51:29+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,14805200000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3,,2019-09-30,2019-11-05 07:47:53+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,1384800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3,,2019-09-30,2019-11-05 07:47:53+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,1493100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3,,2019-09-30,2019-11-05 07:47:53+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,2660000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3,,2019-09-30,2019-11-05 07:47:53+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,1344300000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3,,2019-09-30,2019-11-05 07:47:53+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,226900000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3,,2019-09-30,2019-11-05 07:47:53+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,7109100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3,,2019-09-30,2019-11-05 07:47:53+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2771400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3,,2019-09-30,2019-11-05 07:47:53+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,3112600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3,,2019-09-30,2019-11-05 07:47:53+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,808300000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3,,2019-09-30,2019-11-05 07:47:53+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,137900000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3,,2019-09-30,2019-11-05 07:47:53+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,4058800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3,,2019-09-30,2019-11-05 07:47:53+00:00,,totalassets,Total Assets,=,debit,usd,13939300000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3,,2019-09-30,2019-11-05 07:47:53+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,335600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3,,2019-09-30,2019-11-05 07:47:53+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,821100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3,,2019-09-30,2019-11-05 07:47:53+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,608700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3,,2019-09-30,2019-11-05 07:47:53+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,1765400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3,,2019-09-30,2019-11-05 07:47:53+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,712700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3,,2019-09-30,2019-11-05 07:47:53+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,683800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3,,2019-09-30,2019-11-05 07:47:53+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,273000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3,,2019-09-30,2019-11-05 07:47:53+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,1669500000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3,,2019-09-30,2019-11-05 07:47:53+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,3434900000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3,,2019-09-30,2019-11-05 07:47:53+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3,,2019-09-30,2019-11-05 07:47:53+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,4388400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3,,2019-09-30,2019-11-05 07:47:53+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,6587800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3,,2019-09-30,2019-11-05 07:47:53+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-488400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3,,2019-09-30,2019-11-05 07:47:53+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,16500000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3,,2019-09-30,2019-11-05 07:47:53+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,10504300000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3,,2019-09-30,2019-11-05 07:47:53+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,10504500000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3,,2019-09-30,2019-11-05 07:47:53+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,10504500000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3,,2019-09-30,2019-11-05 07:47:53+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,13939300000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2,,2019-06-30,2019-08-06 07:55:20+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,1045500000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2,,2019-06-30,2019-08-06 07:55:20+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,1624200000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2,,2019-06-30,2019-08-06 07:55:20+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,2455900000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2,,2019-06-30,2019-08-06 07:55:20+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,1317200000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2,,2019-06-30,2019-08-06 07:55:20+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,208200000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2,,2019-06-30,2019-08-06 07:55:20+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,6651000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2,,2019-06-30,2019-08-06 07:55:20+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2676600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2,,2019-06-30,2019-08-06 07:55:20+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,2884600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2,,2019-06-30,2019-08-06 07:55:20+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,821600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2,,2019-06-30,2019-08-06 07:55:20+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,139800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2,,2019-06-30,2019-08-06 07:55:20+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,3846000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2,,2019-06-30,2019-08-06 07:55:20+00:00,,totalassets,Total Assets,=,debit,usd,13173600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2,,2019-06-30,2019-08-06 07:55:20+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,244000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2,,2019-06-30,2019-08-06 07:55:20+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,876700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2,,2019-06-30,2019-08-06 07:55:20+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,592400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2,,2019-06-30,2019-08-06 07:55:20+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,1713100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2,,2019-06-30,2019-08-06 07:55:20+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,711300000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2,,2019-06-30,2019-08-06 07:55:20+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,725400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2,,2019-06-30,2019-08-06 07:55:20+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,267900000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2,,2019-06-30,2019-08-06 07:55:20+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,1704600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2,,2019-06-30,2019-08-06 07:55:20+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,3417700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2,,2019-06-30,2019-08-06 07:55:20+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2,,2019-06-30,2019-08-06 07:55:20+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,4263600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2,,2019-06-30,2019-08-06 07:55:20+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,5918200000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2,,2019-06-30,2019-08-06 07:55:20+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-441800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2,,2019-06-30,2019-08-06 07:55:20+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,15800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2,,2019-06-30,2019-08-06 07:55:20+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,9755800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2,,2019-06-30,2019-08-06 07:55:20+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,9756000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2,,2019-06-30,2019-08-06 07:55:20+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,9756000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2,,2019-06-30,2019-08-06 07:55:20+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,13173600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1,,2019-03-31,2019-05-07 07:50:15+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,1708500000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1,,2019-03-31,2019-05-07 07:50:15+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,1523900000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1,,2019-03-31,2019-05-07 07:50:15+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,2305200000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1,,2019-03-31,2019-05-07 07:50:15+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,1208800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1,,2019-03-31,2019-05-07 07:50:15+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,182200000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1,,2019-03-31,2019-05-07 07:50:15+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,6928600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1,,2019-03-31,2019-05-07 07:50:15+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2612800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1,,2019-03-31,2019-05-07 07:50:15+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,2339800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1,,2019-03-31,2019-05-07 07:50:15+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,829300000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1,,2019-03-31,2019-05-07 07:50:15+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,144300000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1,,2019-03-31,2019-05-07 07:50:15+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,3313400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1,,2019-03-31,2019-05-07 07:50:15+00:00,,totalassets,Total Assets,=,debit,usd,12854800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1,,2019-03-31,2019-05-07 07:50:15+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,239600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1,,2019-03-31,2019-05-07 07:50:15+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,741100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1,,2019-03-31,2019-05-07 07:50:15+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,530700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1,,2019-03-31,2019-05-07 07:50:15+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,1511400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1,,2019-03-31,2019-05-07 07:50:15+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,709900000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1,,2019-03-31,2019-05-07 07:50:15+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,812500000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1,,2019-03-31,2019-05-07 07:50:15+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,376300000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1,,2019-03-31,2019-05-07 07:50:15+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,1898700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1,,2019-03-31,2019-05-07 07:50:15+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,3410100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1,,2019-03-31,2019-05-07 07:50:15+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1,,2019-03-31,2019-05-07 07:50:15+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,4160900000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1,,2019-03-31,2019-05-07 07:50:15+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,5725100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1,,2019-03-31,2019-05-07 07:50:15+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-444200000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1,,2019-03-31,2019-05-07 07:50:15+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,2800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1,,2019-03-31,2019-05-07 07:50:15+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,9444600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1,,2019-03-31,2019-05-07 07:50:15+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,9444800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1,,2019-03-31,2019-05-07 07:50:15+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,9444800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1,,2019-03-31,2019-05-07 07:50:15+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,12854800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1,,2020-03-31,2020-05-05 07:51:29+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,2208200000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1,,2020-03-31,2020-05-05 07:51:29+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,1795200000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1,,2020-03-31,2020-05-05 07:51:29+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,2933200000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1,,2020-03-31,2020-05-05 07:51:29+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,1480900000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1,,2020-03-31,2020-05-05 07:51:29+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,226600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1,,2020-03-31,2020-05-05 07:51:29+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,8644100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1,,2020-03-31,2020-05-05 07:51:29+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2944600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1,,2020-03-31,2020-05-05 07:51:29+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,3236400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1,,2020-03-31,2020-05-05 07:51:29+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,771200000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1,,2020-03-31,2020-05-05 07:51:29+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,161200000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1,,2020-03-31,2020-05-05 07:51:29+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,4168800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1,,2020-03-31,2020-05-05 07:51:29+00:00,,totalassets,Total Assets,=,debit,usd,15757500000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1,,2020-03-31,2020-05-05 07:51:29+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,347800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1,,2020-03-31,2020-05-05 07:51:29+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,1143200000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1,,2020-03-31,2020-05-05 07:51:29+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,479200000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1,,2020-03-31,2020-05-05 07:51:29+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,85000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1,,2020-03-31,2020-05-05 07:51:29+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,2055200000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1,,2020-03-31,2020-05-05 07:51:29+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,715200000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1,,2020-03-31,2020-05-05 07:51:29+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,82100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1,,2020-03-31,2020-05-05 07:51:29+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,772000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1,,2020-03-31,2020-05-05 07:51:29+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,1569300000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1,,2020-03-31,2020-05-05 07:51:29+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,3624500000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1,,2020-03-31,2020-05-05 07:51:29+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1,,2020-03-31,2020-05-05 07:51:29+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,5211400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1,,2020-03-31,2020-05-05 07:51:29+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,8004400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1,,2020-03-31,2020-05-05 07:51:29+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-1073800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1,,2020-03-31,2020-05-05 07:51:29+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-9100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1,,2020-03-31,2020-05-05 07:51:29+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,12132900000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1,,2020-03-31,2020-05-05 07:51:29+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,12133000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1,,2020-03-31,2020-05-05 07:51:29+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,12133000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1,,2020-03-31,2020-05-05 07:51:29+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,15757500000.0
